Ledger.Open graph →
SEC Form D · Amendment · filed August 18, 2020

Kriya Therapeutics, Inc

Offering
$87.6M
Sold
$87.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Ilan Oren · Palo Alto, CADirectorShankar Ramaswamy · Palo Alto, CAExec · DirectorC.R. Sincock · Palo Alto, CADirectorKeith Manchester · Palo Alto, CADirectorRoger Jeffs · Palo Alto, CADirectorJohn T. Pena · New York, NYExec · DirectorChetan R. Mukundan, M.D · Nashville, TNDirectorEmmanuel R. Desousa · Grand Cayman, Cayman IslandsDirectorAmber Ramsey · George Town, Cayman IslandsDirectorH. L. Remmel · New York, NYDirectorMoshe Hecht · Pomona, NYDirectorMatthew Kinley · Los Angeles, CADirectorMichael V. Banks · AUSTIN, TXDirectorEric D. Andersen · Los Angeles, CAExec · DirectorEd Murray · Davie, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗